期刊文献+

超声检查对小肠间质瘤的诊断价值 被引量:1

Diagnostic value of small bowel stromal tumors with ultrasonography
下载PDF
导出
摘要 目的探讨超声检查对小肠间质瘤的临床诊断价值。方法对福建省肿瘤医院2008年4月至2015年5月收治且经手术及病理证实的39例小肠间质瘤患者的超声资料进行回顾性分析。结果按病理危险分级标准将39例患者分为极低危组(1例)、低危组(11例)、中等危组(1例)、高危组(26例)。超声诊断符合率为64.1%(25/39),漏诊2例(5.1%)。低危组病灶超声表现均呈边界清楚的低回声团块,多呈类圆形,内部回声均匀,团块内部多见Ⅰ级血流信号(63.6%,7/11);高危组病灶呈囊实性和低回声,团块多数边界清楚,但内部回声不均,46.2%呈分叶状,团块内部多见Ⅱ~Ⅲ级血流信号(61.5%,16/26)。结论超声作为临床应用最广的检查项目之一,对小肠间质瘤的术前筛查具有重要价值,结合临床表现有助于提高其诊断率。 Objective To investigate the clinical value of ultrasonography( US) in diagnosing small bowel stromal tumors( SBST). Methods 39 SBST patients pathologically confirmed from April 2008 to May 2015 in our hospital were evaluated retrospectively. Results 39 patients were divided into very low-risk group( n = 1),low-risk group( n = 11),moderate-risk group( n = 1),and high-risk group( n = 26) based on the risk of malignancy. The coincidence rate of US was 64. 1%( 25 /39). Only 2 cases were misdiagnosed( 5. 1%,2 /39). The ultrasonic images in the low-risk group( n = 11) showed that the masses were like-round,with even low echo and clear boundary,and the I visible class blood flow signals were detected in the masses of 7 cases in this group( 63. 6%,7 /11). The ultrasonic images in the high-risk group( n = 26) showed cystic and solid masses with uneven low echo and clear boundary,and the masses of 12 cases in this group( 46. 2%,12 /26) were lobulated,and the Ⅱ ~ Ⅲ visible class blood flow signals were detected in 16 cases( 61. 5%,16 /26). Conclusions There was a certain clinical value for preoperative diagnosis of SBST by using color doppler ultrasound.The diagnostic rate should be improved by considering of both ultrasound manifestations and clinical features.
出处 《中国肿瘤外科杂志》 CAS 2016年第1期30-32,共3页 Chinese Journal of Surgical Oncology
基金 国家临床重点专科建设项目资助
关键词 小肠间质瘤 超声检查 诊断 Small bowel stromal tumors Ultrasounography Diagnosis
  • 相关文献

参考文献7

  • 1GROVER S, ASHLEY S W, RAUT C P. Small intestine gastroin- testinal stromal tumors[ J ]. Curr Opin Gastroenterol,2012,28 ( 2 ) : 113-123.
  • 2ADLER D D, CARSON P L, RUBIN J M, et al. Doppler ultra- sound color Now imaging in the study of breast cancer: Prelinfinary findings[ J ]. Ultrasound Med Biol, 1990, 16 (6) :553-559.
  • 3JOENSUU H. Risk stratification of patients diagnosed with gastro- intestinal stromal tumor[ J]. Hure Pathol, 2008, 39 (10) : 1411- 1419.
  • 4FAIGEL D O, ABULHAWA S. Gastrointestinal stromal tumors: the role of the gastroenterologist in diagnosis and risk stratification[ J ]. Clin Gastroentero1,2012,46( 8 ) :629-636.
  • 5丁伟超,张蓬波,张秀忠,张冲,任泽强.胃肠道间质瘤的术前诊断分析[J].中国肿瘤外科杂志,2014,6(1):54-56. 被引量:7
  • 6过兆基,吕庆福,曹苇,朱麟,胡浩.胃肠道间质瘤的诊断和外科治疗[J].中国肿瘤外科杂志,2011,3(2):77-79. 被引量:5
  • 7OKAI T, MINAMOTO T, OttTSUBO K, et al. Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor [ J ]. Ab- dora Imaging 2003, 28(3) : 301-307.

二级参考文献18

  • 1Miettinen M, Lasota J clinical, histological, Gastrointestinal stromal tumors--definition ic features and differential 438(1) :1-12. mohistochemieal, and molecular genetdiagnosis [ J]. Virchows Arch, 2001,.
  • 2Nisson B, Brimming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors : the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden[ J]. Cancer, 2005, 103 (4) :821-829.
  • 3Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach : a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up [J]. Am J Surg Pathol, 2005, 29(1) :52-68.
  • 4Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor [ J ]. Hum Pathol, 2008, 39 ( 10 ) : 1411-1419.
  • 5Zalcberg JR, Verweij J, Casali PG, et al. Outcome of patients with advanced gastro-intestinal stromal tumors crossing over tO a daily imstinib dose of 800mg after progression on 400mg[J]. Eur J Cancer, 2005, 41 (12) :1751-1757.
  • 6Park I, Ryu MH, Sym SJ, et al. Dose escalation of imatinib after failure of standard dise in Korean patients with metastatic or unressectable gastrointestinal stromal tumor [ J ]. Jpn J Clin Oncol, 2009, 39 ( 2 ) : 105-110.
  • 7Dirnhofer S, Leyvraz S. Current standards and progress in understanding and treatment of GIST [ J ]. Swiss Med Wkly, 2009,139 (7-8) :90-102.
  • 8Antonescu CR. The GIST paradigm: lessons for other kinase-dfiven cancers[J]. J Fathol, 2011, 223(2) :251-261.
  • 9Yucel AF, Sunar H, Hut A, et al. Gastrointestinal stromal tumors with unusual localization:report of three cases with a brief litera- ture review[ J]. Case Rep Gastroenterol,2010,4(2) :250-260.
  • 10Joensuu H. Risk stratification of patients diagnosed with gastroin- testinal stromal tumor [ J ]. Hum Pathol, 2008, 39 (10): 1411-1419.

共引文献10

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部